Connor, Clark & Lunn Investment Management (CC&L)
RMTI icon

Connor, Clark & Lunn Investment Management (CC&L)’s Rockwell Medical RMTI Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-145
Closed -$33K – 1157
2020
Q1 		$33K Buy
+145
New +$41.3K ﹤0.01% 976

Other funds holding RMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SW
SkyOak Wealth Southfield, Michigan $612M AUM 23.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s RMTI Position: Q2 2020 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Rockwell Medical (RMTI) in Q2 2020, closing a stake of 145 shares — an estimated $33K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in RMTI in Q1 2020 and held it in 1 quarter. The position peaked at $33K in Q1 2020. 79 funds tracked by Wall St. Rank hold RMTI as of Q2 2020.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Rockwell Medical position as of Q2 2020 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 145 Rockwell Medical shares in Q2 2020, an estimated $33K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Rockwell Medical in Q1 2020 and held it in 1 quarter.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Rockwell Medical position peaked at $33K in Q1 2020.
  • 79 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2020.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2020, filed 13 Aug 2020.